DCM
AGTC

Dupont Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Dupont Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-36,509
Closed -$252K – 1005
2017
Q1 		$252K Hold
36,509
– – 0.01% 798
2016
Q4 		$341K Hold
36,509
– – 0.01% 757
2016
Q3 		$357K Hold
36,509
– – 0.01% 610
2016
Q2 		$516K Buy
+36,509
New +$570K 0.01% 570

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dupont Capital Management's AGTC Position: Q2 2017 in Review

Dupont Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 36,509 shares — an estimated $252K sold.

Dupont Capital Management first reported a position in AGTC in Q2 2016 and held it in 4 quarters. The position peaked at $516K in Q2 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • Dupont Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • Dupont Capital Management sold 36,509 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $252K.
  • Dupont Capital Management first reported a position in Applied Genetic Technologies Corporation in Q2 2016 and held it in 4 quarters.
  • Dupont Capital Management's Applied Genetic Technologies Corporation position peaked at $516K in Q2 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on Dupont Capital Management's 13F filing for Q2 2017, filed 3 Aug 2017.